The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9
暂无分享,去创建一个
M. Rubin | M. Stifelman | N. Bander | J. McKiernan | C. Olsson | A. De la taille | R. Buttyan | E. Bagiella | A. Katz | I. Sawczuk | E. Emanuel | Alexandre de la Taille | Carl A. Olsson | Ihor S. Sawczuk | James M. McKiernan | Ralph Buttyan | Neil H. Bander | Alexandre de la Taille | Michael D. Stifelman | Eric R. Emanuel | Emilia Bagiella | E. R. Emanuel
[1] P. Elson. Prognostic Factors in Metastatic Renal Cell Carcinoma , 2000 .
[2] P. Pisters. Chemoradiation treatment strategies for localized sarcoma: conventional and investigational approaches. , 1999, Seminars in surgical oncology.
[3] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[4] E. Stanbridge,et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. , 1997, Cancer research.
[5] M. Stifelman,et al. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. , 1997, Cancer research.
[6] J. Pastorek,et al. Transient transformation of mammalian cells by MN protein, a tumor-associated cell adhesion molecule with carbonic anhydrase activity. , 1997, International journal of oncology.
[7] K. Junker,et al. Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. , 1998, Cytokine.
[8] G. Snow,et al. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. , 1996, Anticancer research.
[9] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[10] E. Levine,et al. Detection of tyrosinase mRNA from the blood of melanoma patients. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] F. Marshall,et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. , 1995, Urology.
[12] K. Pittman,et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.
[13] R. Kettmann,et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.
[14] P. Disaia,et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. , 1994, The American journal of pathology.
[15] M. Benson,et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.
[16] E. Dmitrovsky,et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. , 1993, Blood.
[17] A. Gross,et al. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma? , 1993, European urology.
[18] S. Pastoreková,et al. A novel quasi-viral agent, MaTu, is a two-component system. , 1992, Virology.
[19] K. Grankvist,et al. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. , 1992, European urology.
[20] I. Moro,et al. Tumor markers in human renal cell carcinoma. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[21] M. Melamed,et al. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. , 1989, Cancer research.
[22] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[23] J. Dekernion,et al. Prognostic factors in metastatic renal carcinoma. , 1986, The Journal of urology.
[24] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[25] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .